Teva Launches Generic Actos
Pioglitazone HCl tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and as monotherapy or in combination with metformin, insulin, or a sulfonylurea. It is not for the treatment of type 1 diabetes or diabetic ketoacidosis.
Teva's Pioglitazone HCl tablets are available in 15mg, 30mg, and 45mg dosage strengths in 30-, 90-, and 500-count bottles.
For more information call (215) 591-3000 or visit www.tevausa.com.